title: Spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.
authors.forename: Teresa
authors.initials: T
authors.lastname: Otón
authors.forename: Lucía
authors.initials: L
authors.lastname: Silva-Fernández
authors.forename: José Luis
authors.initials: JL
authors.lastname: Andreu
mesh_terms: D000631:Aminopyridines; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000037:antagonists & inhibitors*; D008727:Methotrexate / Q000008:administration & dosage*; D009025:Morpholines; D010078:Oxazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011725:Pyridines / Q000627:therapeutic use*; D011743:Pyrimidines; D000072377:Syk Kinase
chemical_list: D000631:Aminopyridines; D018501:Antirheumatic Agents; D047908:Intracellular Signaling Peptides and Proteins; D009025:Morpholines; D010078:Oxazines; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D011743:Pyrimidines; D011505:Protein-Tyrosine Kinases; C000606896:SYK protein, human; D000072377:Syk Kinase; C523665:fostamatinib; D008727:Methotrexate